GTHP
OQB Guided Therapeutics, Inc.$0.1900 ↑ +0.0100 (+5.56%) Trading Up from the previous close of $0.1800, and at the day’s high of $0.1900
- YTD change
- -64.81%
- vs 20-day SMA
- -14.14%
- vs 200-day SMA
- -30.78%
Price ranges
Price & Performance
-0.01 (-5.00%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 81.0% away from all-time highs of $1.0000
- GTHP is down 65% since the beginning of the year
- GTHP is down 32% over the past 12 months
- GTHP is down 18% over the past 1 month
- 0% of all GTHP investors are betting against GTHP
GTHP reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is -22.4%.
- Previous minute
- +$0.0000
- Last hour
- +$0.0000
- Last 5 days
- -23.36%
- vs 8-day SMA
- -8.42%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Guided Therapeutics, Inc. is a medical technology company, which engages in developing medical devices. It also focuses on the selling and marketing of its LuViva advanced cervical scan non-invasive cervical cancer detection device. The company was founded by Shabbir Bakir Bambot and Mark L. Faupel in 1992 and is headquartered in Peachtree Corners, GA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.